With the increasing rollout of COVID-19 vaccines globally, what problems are emerging and should these deter someone from being jabbed?
With the increasing rollout of COVID-19 vaccines globally, what problems are emerging and should these deter someone from being jabbed?
Last week Dr Ross told us what happens when diabetics have coffee and tea every day, but what are the benefits for non-diabetics?
This is the riskiest story I’ve ever written but someone needs to have the guts to address issues that shouldn’t be ignored.
Put on your dancing shoes, we’re in for a rip roaring time. While nothing’s forever and pessimists will always be pessimists, let the good times roll.
Whilst some cannabis stocks can trade on hype and future earnings potential, Bod Australia (ASX: BDA) has much more than that going for it.
Travel stocks continued to feature in the most traded stocks this week, including Flight Centre (FLT), Qantas (QAN) and Webjet (WEB).
Economists remain hopeful about Australia’s recovery over the coming years.
Peter Switzer is joined by Michael Wayne from Medallion Financial Group, Kieran Davies from Coolabah Capital and James Symond from Aussie Home Loans.
If there’s anything more worrying than the Coronavirus, the viral popularity of tattoos and mullet haircuts, it’s talk of death taxes!
Fill in the form below to subscribe to Switzer Daily and get our latest articles, videos and podcasts sent straight to your inbox